Quantum Biopharma (QNTM.CN) Stock Price
Quantum Biopharma Price
Quantum Biopharma's net margin stands at -20,230.8%, up from -25,579.6% several years earlier.
Quantum Biopharma stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Quantum Biopharma business model & stock analysis
Frequently asked questions about Quantum Biopharma
7 analysts currently rate the Quantum Biopharma stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Quantum Biopharma share trades at 2.16 EUR (2.43 USD).
The revenue cannot currently be calculated for Quantum Biopharma.
The expected profit of Quantum Biopharma is -6.98 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Quantum Biopharma is currently -1.35. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Quantum Biopharma stock.
The P/S cannot be calculated for Quantum Biopharma currently.
The Eulerpool Quality Score for Quantum Biopharma is 2/10.
The ISIN of Quantum Biopharma is CA74764Y2050. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Quantum Biopharma is QNTM.CN. The ticker symbol is used to trade Quantum Biopharma shares on the stock exchange.
Quantum Biopharma stock
Quantum Biopharma Peer Group
All fundamentals and in-depth analysis of Quantum Biopharma
Our stock analysis for Quantum Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quantum Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.